Effect of lipoxin A4 on myocardial ischemia reperfusion injury following cardiac arrest in a rabbit model

Inflammation

Volumn 36, Issue 2, 2013, Pages 468-475

  Chen, Zhiqiao ^a,b   Wu, Zhe ^c   Huang, Congxin ^a   Zhao, Yan ^a,b   Zhou, Yirong ^c   Zhou, Xianlong ^c   Lu, Xingxing ^c   Mao, Lele ^c   Li, Siying ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

cardiac arrest (CA); cardiopulmonary resuscitation (CPR); inflammation; ischemia reperfusion injury (IRI); lipoxin A4

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOXIN A; TRANSCRIPTION FACTOR RELA; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; APOPTOTIC INDEX; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG RESPONSE; FATTY ACID ANALYSIS; FEMALE; HEART ARREST; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INFARCT RATIO; MALE; MYOCARDITIS; NONHUMAN; PROTEIN EXPRESSION; RABBIT; REPERFUSION INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; FEMALE; HEART ARREST; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOXINS; MALE; MYOCARDIAL REPERFUSION INJURY; NF-KAPPA B; RABBITS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

ORYCTOLAGUS CUNICULUS;

EID: 84877624393     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9567-x     Document Type: Article

References (32)

1. de Vreede-Swagemakers, J.J.M.; A.P.M. Gorgels, W.I. Dubois-Arbouw, J.W. van Ree, M.J.A.P. Daemen, L.G.E. Houben, and H.J.J. Wellens. 1997. Out-of-hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. Journal of the American College of Cardiology 30(6): 1500-1505.
2. Geppert, A.; G. Zorn, G.D. Karth, M. Haumer, M. Gwechenberger, J. Koller-Strametz, G. Heinz, K. Huber, and P. Siostrzonek. 2000. Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Critical Care Medicine 28(7): 2360-2365.
3. Adrie, C.; M. Adib-Conquy, I. Laurent, M. Monchi, C. Vinsonneau, C. Fitting, F. Fraisse, A.T. Dinh-Xuan, P. Carli, C. Spaulding, J.F. Dhainaut, and J.M. Cavaillon. 2002. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 106(5): 562-568.
4. Nolan, J.P.; R.W. Neumar, C. Adrie, M. Aibiki, R.A. Berg, B.W. Bbttiger, C. Callaway, R.S. Clark, R.G. Geocadin, E.C. Jauch, K.B. Kern, I. Laurent, W.T. Longstreth, R.M. Merchant, P. Morley, L.J. Morrison, V. Nadkarni, M.A. Peberdy, E.P. Rivers, A. Rodriguez-Nunez, F.W. Sellke, C. Spaulding, K. Sunde, and H.T. Vanden. 2010. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication: a scientific statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke (Part II). International Emergency Nursing 18(1): 8-28.
5. Cook-Mills, J.M.; and T.L. Deem. 2005. Active participation of endothelial cells in inflammation. Journal of Leukocyte Biology 77(4): 487-495.
6. Boyle, E.J.; T.J. Canty, E.N. Morgan, W. Yun, T.H. Pohlman, and E.D. Verrier. 1999. Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription. The Annals of Thoracic Surgery 68(5): 1949-1953.
7. Serhan, C.N.; and E. Oliw. 2001. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. Journal Clinical Investigations 107(12): 1481-1489.
8. Ye, X.H.; Y. Wu, P.P. Guo, J. Wang, S.Y. Yuan, Y. Shang, and S.L. Yao. 2010. Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Research 1323: 174-183.
9. Leonard, M.O.; K. Hannan, M.J. Burne, D.W. Lappin, P. Doran, P. Coleman, C. Stenson, C.T. Taylor, F. Daniels, C. Godson, N.A. Petasis, H. Rabb, and H.R. Brady. 2002. 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. Journal of the American Society of Nephrology 13(6): 1657-1662.
10. Peskar, B.M.; K. Ehrlich, R. Schuligoi, and B.A. Peskar. 2009. Role of lipoxygenases and the lipoxin A(4)/annexin 1 receptor in ischemia-reperfusion- induced gastric mucosal damage in rats. Pharmacology 84(5): 294-299.
11. Serhan, C.N.; A. Jain, S. Marleau, C. Clish, A. Kantarci, B. Behbehani, S.P. Colgan, G.L. Stahl, A. Merched, N.A. Petasis, L. Chan, and T.E. Van Dyke. 2003. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. Journal of Immunology 171(12): 6856-6865.
12. Takano, T.; C.B. Clish, K. Gronert, N. Petasis, and C.N. Serhan. 1998. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. Journal of Clinical Investigation 101(4): 819-826.
13. Takano, T.; S. Fiore, J.F. Maddox, H.R. Brady, N.A. Petasis, and C.N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. The Journal of Experimental Medicine 185(9): 1693-1704.
14. Devchand, P.R.; M. Arita, S. Hong, G. Bannenberg, R.L. Moussignac, K. Gronert, and C.N. Serhan. 2003. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. The FASEB Journal 17(6): 652-659.
15. Birnbaum, Y.; Y. Ye, Y. Lin, S.Y. Freeberg, S.P. Nishi, J.D. Martinez, M.H. Huang, B.F. Uretsky, and J.R. Perez-Polo. 2006. Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. Circulation 114(9): 929-935.
16. Chen, M.H.; L. Xie, T.W. Liu, F.Q. Song, T. He, Z.Y. Zeng, and S.R. Mo. 2007. Epinephrine, but not vasopressin, improves survival rates in an adult rabbit model of asphyxia cardiac arrest. The American Journal of Emergency Medicine 25(5): 509-514.
17. Hammel, J.M.; C.A. Caldarone, T.L. Van Natta, L.X. Wang, K.F. Welke, W. Li, S. Niles, E. Barner, T.D. Scholz, D.M. Behrendt, and J.L. Segar. 2003. Myocardial apoptosis after cardioplegic arrest in the neonatal lamb. The Journal of Thoracic and Cardiovascular Surgery 125(6): 1268-1275.
18. Borutaite, V.; and G.C. Brown. 2003. Mitochondria in apoptosis of ischemic heart. FEBS Letters 541(1-3): 1-5.
19. Song, F.; Y. Shan, F. Cappello, F. Rappa, G. Ristagno, T. Yu, V.G. Li, S. Sun, M.H. Weil, and W. Tang. 2010. Apoptosis is not involved in the mechanism of myocardial dysfunction after resuscitation in a rat model of cardiac arrest and cardiopulmonary resuscitation. Critical Care Medicine 38(5): 1329-1334.
20. Ryan, A.; and C. Godson. 2010. Lipoxins: regulators of resolution. Current Opinion in Pharmacology 10(2): 166-172.
21. Wu, J.; A. Wang, Z. Min, Y. Xiong, Q. Yan, J. Zhang, J. Xu, and S. Zhang. 2011. Lipoxin A4 inhibits the production of proinflammatory cytokines induced by beta-amyloid in vitro and in vivo. Biochemistry Biophysics Research Communication 408(3): 382-387.
22. Baker, N.; S.J. O'Meara, M. Scannell, P. Maderna, and C. Godson. 2009. Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells. Journal of Immunology 182(6): 3819-3826.
23. Turer, A.T.; and J.A. Hill. 2010. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. The American Journal of Cardiology 106(3): 360-368.
24. Laurent, I.; M. Monchi, J.D. Chiche, L.M. Joly, C. Spaulding, B. Bourgeois, A. Cariou, A. Rozenberg, P. Carli, S. Weber, and J.F. Dhainaut. 2002. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. Journal of the American College of Cardiology 40(12): 2110-2116.
25. Ruiz-Bailen, M.; D.H.E. Aguayo, S. Ruiz-Navarro, M.A. Diaz-Castellanos, L. Rucabado-Aguilar, F.J. Gomez-Jimenez, S. Martinez-Escobar, R.M. Moreno, and J. Fierro-Roson. 2005. Reversible myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation 66(2): 175-181.
26. Weerateerangkul, P.; S. Chattipakorn, and N. Chattipakorn. 2011. Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury. Medical Science Monitor 17(2): A44-A52.
27. Vinten-Johansen, J.; R. Jiang, J.G. Reeves, J. Mykytenko, J. Deneve, and L.J. Jobe. 2007. Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion Injury. Hematology/Oncology Clinics of North America 21(1): 123-145.
28. Moro, C.; M.G. Jouan, A. Rakotovao, M.C. Toufektsian, O. Ormezzano, N. Nagy, A. Tosaki, J. de Leiris, and F. Boucher. 2007. Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling. America Journal Physiology Heart Circulatory Physiology 293(5): H3014-H3019.
29. Baker, R.G.; M.S. Hayden, and S. Ghosh. 2011. NF-kappaB, inflammation, and metabolic disease. Cell Metabolism 13(1): 11-22.
30. Souza, D.G.; C.T. Fagundes, F.A. Amaral, D. Cisalpino, L.P. Sousa, A.T. Vieira, V. Pinho, J.R. Nicoli, L.Q. Vieira, I.M. Fierro, and M.M. Teixeira. 2007. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. Journal of Immunology 179(12): 8533-8543.
31. Jozsef, L.; C. Zouki, N.A. Petasis, C.N. Serhan, and J.G. Filep. 2002. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Processing Nationale Academie Science U S A 99(20): 13266-13271.
32. Yang, J.; H. Jiang, J. Yang, J.W. Ding, L.H. Chen, S. Li, and X.D. Zhang. 2009. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway. Molecular and Cellular Biochemistry 330(1-2): 39-46.